Short-Term Outcome and Hemodynamic Performance of Next-Generation Self-Expanding Versus Balloon-Expandable Transcatheter Aortic Valves in Patients with Small Aortic Annulus: A Multicenter Propensity-Matched Comparison

Circulation: Cardiovascular Interventions

Volumn 10, Issue 10, 2017, Pages

  Mauri, Victor ^a   Kim, Won K ^a   Abumayyaleh, Mohammad ^a   Walther, Thomas ^b   Moellmann, Helge ^d   Schaefer, Ulrich ^e   Conradi, Lenard ^f   Hengstenberg, Christian ^g,h   Hilker, Michael ^i,j,k   Wahlers, Thorsten ^c   Baldus, Stephan ^a   Rudolph, Volker ^a   Madershahian, Navid ^b   Rudolph, Tanja K ^a  

^a UNIVERSITY OF COLOGNE   (Germany)

^b Cardiothoracic Surgery   (Germany)

^c Departments of Cardiology   (Germany)

^d KERCKHOFF HEART CENTER   (Germany)

^e ST JOHANNES HOSPITAL   (Germany)

^f Departments of General and Interventional Cardiology   (Germany)

^g Cardiovascular Surgery   (Germany)

^h UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

ⁱ TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^j DZHK GERMAN CENTRE FOR CARDIOVASCULAR RESEARCH   (Germany)

^k UNIVERSITY HOSPITAL REGENSBURG   (Germany)

more..

Author keywords

follow up studies; heart valve prosthesis; pacemaker, artificial; propensity score; transcatheter aortic valve replacement

Indexed keywords

AGED; ALL CAUSE MORTALITY; AORTIC DISEASE; ARTICLE; BLEEDING; CEREBROVASCULAR ACCIDENT; CLINICAL OUTCOME; CONVERSION TO OPEN SURGERY; FEMALE; HEART TAMPONADE; HEART VENTRICLE PERFORATION; HEMODYNAMICS; HUMAN; MAJOR CLINICAL STUDY; MALE; MITRAL VALVE REGURGITATION; MULTICENTER STUDY; PACEMAKER IMPLANTATION; PRIORITY JOURNAL; RENOVASCULAR DISEASE; SMALL AORTIC ANNULUS; TRANSCATHETER AORTIC VALVE IMPLANTATION; VERY ELDERLY; ADVERSE DEVICE EFFECT; AORTIC VALVE; CLINICAL TRIAL; COMPARATIVE STUDY; DEVICES; HEART VALVE PROSTHESIS; PROPENSITY SCORE; STATISTICS AND NUMERICAL DATA;

AGED; AGED, 80 AND OVER; AORTIC VALVE; FEMALE; HEART VALVE PROSTHESIS; HEMODYNAMICS; HUMANS; MALE; PROPENSITY SCORE; TRANSCATHETER AORTIC VALVE REPLACEMENT;

EID: 85040791588     PISSN: 19417640     EISSN: 19417632     Source Type: Journal    
DOI: 10.1161/CIRCINTERVENTIONS.117.005013     Document Type: Article

References (32)

1. Pibarot P, Dumesnil JG, Prosthetic heart valves: selection of the optimal prosthesis and long-Term management. Circulation 2009 119 1034 1048. doi: 10.1161/CIRCULATIONAHA.108.778886.
2. Head SJ, Mokhles MM, Osnabrugge RL, Pibarot P, Mack MJ, Takkenberg JJ, Bogers AJ, Kappetein AP, The impact of prosthesis-patient mismatch on long-Term survival after aortic valve replacement: A systematic review and meta-Analysis of 34 observational studies comprising 27 186 patients with 133 141 patient-years. Eur Heart J 2012 33 1518 1529. doi: 10.1093/eurheartj/ehs003.
3. Dayan V, Vignolo G, Soca G, Paganini JJ, Brusich D, Pibarot P, Predictors and outcomes of prosthesis-patient mismatch after aortic valve replacement. JACC Cardiovasc Imaging 2016 9 924 933. doi: 10.1016/j.jcmg.2015.10.026.
4. Flameng W, Herregods MC, Vercalsteren M, Herijgers P, Bogaerts K, Meuris B, Prosthesis-patient mismatch predicts structural valve degeneration in bioprosthetic heart valves. Circulation 2010 121 2123 2129. doi: 10.1161/CIRCULATIONAHA.109.901272.
5. Ghoneim A, Bouhout I, Demers P, Mazine A, Francispillai M, El-Hamamsy I, Carrier M, Lamarche Y, Bouchard D, Management of small aortic annulus in the era of sutureless valves: A comparative study among different biological options. J Thorac Cardiovasc Surg 2016 152 1019 1028. doi: 10.1016/j.jtcvs.2016.06.058.
6. Peterson MD, Borger MA, Feindel CM, David TE, Aortic annular enlargement during aortic valve replacement: improving results with time. Ann Thorac Surg 2007 83 2044 2049. doi: 10.1016/j.athoracsur.2007.01.059.
7. Pibarot P, Weissman NJ, Stewart WJ, Hahn RT, Lindman BR, McAndrew T, Kodali SK, Mack MJ, Thourani VH, Miller DC, Svensson LG, Herrmann HC, Smith CR, Rodés-Cabau J, Webb J, Lim S, Xu K, Hueter I, Douglas PS, Leon MB, Incidence and sequelae of prosthesis-patient mismatch in transcatheter versus surgical valve replacement in high-risk patients with severe aortic stenosis: A PARTNER trial cohort-A analysis. J Am Coll Cardiol 2014 64 1323 1334. doi: 10.1016/j.jacc.2014.06.1195.
8. Zorn GL 3rd, Little SH, Tadros P, Deeb GM, Gleason TG, Heiser J, Kleiman NS, Oh JK, Popma JJ, Adams D, Huang J, Reardon MJ, Prosthesis-patient mismatch in high-risk patients with severe aortic stenosis: A randomized trial of a self-expanding prosthesis. J Thorac Cardiovasc Surg 2016 151 1014 1022, 1023.e1. doi: 10.1016/j.jtcvs.2015.10.070.
9. Möllmann H, Diemert P, Grube E, Baldus S, Kempfert J, Abizaid A, Symetis ACURATE TF™ aortic bioprosthesis. EuroIntervention 2013 9 (suppl) S107 S110. doi: 10.4244/EIJV9SSA22.
10. Binder RK, Rodés-Cabau J, Wood DA, Mok M, Leipsic J, De Larochellière R, Toggweiler S, Dumont E, Freeman M, Willson AB, Webb JG, Transcatheter aortic valve replacement with the SAPIEN 3: A new balloon-expandable transcatheter heart valve. JACC Cardiovasc Interv 2013 6 293 300. doi: 10.1016/j.jcin.2012.09.019.
11. Kappetein AP, Head SJ, Généreux P, Piazza N, van Mieghem NM, Blackstone EH, Brott TG, Cohen DJ, Cutlip DE, van Es GA, Hahn RT, Kirtane AJ, Krucoff MW, Kodali S, Mack MJ, Mehran R, Rodés-Cabau J, Vranckx P, Webb JG, Windecker S, Serruys PW, Leon MB, Valve Academic Research Consortium-2 Updated standardized endpoint definitions for transcatheter aortic valve implantation: The Valve Academic Research Consortium-2 consensus document. J Thorac Cardiovasc Surg 2013 145 6 23. doi: 10.1016/j.jtcvs.2012.09.002.
12. Athappan G, Gajulapalli RD, Tuzcu ME, Svensson LG, Kapadia SR, A systematic review on the safety of second-generation transcatheter aortic valves. EuroIntervention 2016 11 1034 1043. doi: 10.4244/EIJV11I9A211.
13. Auffret V, Regueiro A, Del Trigo M, Abdul-Jawad Altisent O, Campelo-Parada F, Chiche O, Puri R, Rodés-Cabau J, Predictors of early cerebrovascular events in patients with aortic stenosis undergoing transcatheter aortic valve replacement. J Am Coll Cardiol 2016 68 673 684. doi: 10.1016/j.jacc.2016.05.065.
14. Moellmann H, Results from the global registry SAVI TF. Abstract presented at EuroPCR 2016. May 17, 2016
15. Abdel-Wahab M, Mehilli J, Frerker C, Neumann FJ, Kurz T, Tölg R, Zachow D, Guerra E, Massberg S, Schäfer U, El-Mawardy M, Richardt G, CHOICE Investigators Comparison of balloon-expandable vs self-expandable valves in patients undergoing transcatheter aortic valve replacement: The CHOICE randomized clinical trial. JAMA 2014 311 1503 1514. doi: 10.1001/jama.2014.3316.
16. Chieffo A, Buchanan GL, Van Mieghem NM, Tchetche D, Dumonteil N, Latib A, van der Boon RM, Vahdat O, Marcheix B, Farah B, Serruys PW, Fajadet J, Carrié D, de Jaegere PP, Colombo A, Transcatheter aortic valve implantation with the Edwards SAPIEN versus the Medtronic CoreValve Revalving system devices: A multicenter collaborative study: The PRAGMATIC Plus Initiative (Pooled-RotterdAm-Milano-Toulouse In Collaboration). J Am Coll Cardiol 2013 61 830 836. doi: 10.1016/j.jacc.2012.11.050.
17. Noble S, Stortecky S, Heg D, Tueller D, Jeger R, Toggweiler S, Ferrari E, Nietlispach F, Taramasso M, Maisano F, Grünenfelder J, Jüni P, Huber C, Carrel T, Windecker S, Wenaweser P, Roffi M, Comparison of procedural and clinical outcomes with Evolut R versus Medtronic CoreValve: A Swiss TAVI registry analysis. EuroIntervention 2017 12 e2170 e2176. doi: 10.4244/EIJ-D-16-00677.
18. Manoharan G, Walton AS, Brecker SJ, Pasupati S, Blackman DJ, Qiao H, Meredith IT, Treatment of symptomatic severe aortic stenosis with a novel resheathable supra-Annular self-expanding transcatheter aortic valve system. JACC Cardiovasc Interv 2015 8 1359 1367. doi: 10.1016/j.jcin.2015.05.015.
19. Reardon MJ, Van Mieghem NM, Popma JJ, Kleiman NS, Søndergaard L, Mumtaz M, Adams DH, Deeb GM, Maini B, Gada H, Chetcuti S, Gleason T, Heiser J, Lange R, Merhi W, Oh JK, Olsen PS, Piazza N, Williams M, Windecker S, Yakubov SJ, Grube E, Makkar R, Lee JS, Conte J, Vang E, Nguyen H, Chang Y, Mugglin AS, Serruys PW, Kappetein AP, SURTAVI Investigators Surgical or transcatheter aortic-valve replacement in intermediate-risk patients. N Engl J Med 2017 376 1321 1331. doi: 10.1056/NEJMoa1700456.
20. De Torres-Alba F, Kaleschke G, Diller GP, Vormbrock J, Orwat S, Radke R, Reinke F, Fischer D, Reinecke H, Baumgartner H, Changes in the pacemaker rate after transition from Edwards SAPIEN XT to SAPIEN 3 transcatheter aortic valve implantation: The critical role of valve implantation height. JACC Cardiovasc Interv 2016 9 805 813. doi: 10.1016/j.jcin.2015.12.023.
21. Binder RK, Stortecky S, Heg D, Tueller D, Jeger R, Toggweiler S, Pedrazzini G, Amann FW, Ferrari E, Noble S, Nietlispach F, Maisano F, Raber L, Roffi M, Grunenfelder J, Juni P, Huber C, Windecker S, Wenaweser P, Procedural results and clinical outcomes of transcatheter aortic valve implantation in Switzerland: An observational cohort study of SAPIEN 3 versus SAPIEN XT transcatheter heart valves. Circ Cardiovasc Interv 2015 8 e002653. doi: 10.1161/CIRCINTERVENTIONS.115.002653.
22. Dizon JM, Nazif TM, Hess PL, Biviano A, Garan H, Douglas PS, Kapadia S, Babaliaros V, Herrmann HC, Szeto WY, Jilaihawi H, Fearon WF, Tuzcu EM, Pichard AD, Makkar R, Williams M, Hahn RT, Xu K, Smith CR, Leon MB, Kodali SK, PARTNER Publications Office Chronic pacing and adverse outcomes after transcatheter aortic valve implantation. Heart 2015 101 1665 1671. doi: 10.1136/heartjnl-2015-307666.
23. Tops LF, Schalij MJ, Bax JJ, The effects of right ventricular apical pacing on ventricular function and dyssynchrony implications for therapy. J Am Coll Cardiol 2009 54 764 776. doi: 10.1016/j.jacc.2009.06.006.
24. Elder DH, Lang CC, Choy AM, Pacing-induced heart disease: understanding the pathophysiology and improving outcomes. Expert Rev Cardiovasc Ther 2011 9 877 886. doi: 10.1586/erc.11.82.
25. Athappan G, Patvardhan E, Tuzcu EM, Svensson LG, Lemos PA, Fraccaro C, Tarantini G, Sinning JM, Nickenig G, Capodanno D, Tamburino C, Latib A, Colombo A, Kapadia SR, Incidence, predictors, and outcomes of aortic regurgitation after transcatheter aortic valve replacement: meta-Analysis and systematic review of literature. J Am Coll Cardiol 2013 61 1585 1595. doi: 10.1016/j.jacc.2013.01.047.
26. Kodali S, Pibarot P, Douglas PS, Williams M, Xu K, Thourani V, Rihal CS, Zajarias A, Doshi D, Davidson M, Tuzcu EM, Stewart W, Weissman NJ, Svensson L, Greason K, Maniar H, Mack M, Anwaruddin S, Leon MB, Hahn RT, Paravalvular regurgitation after transcatheter aortic valve replacement with the Edwards sapien valve in the PARTNER trial: characterizing patients and impact on outcomes. Eur Heart J 2015 36 449 456. doi: 10.1093/eurheartj/ehu384.
27. Bocksch W, Grossmann B, Geisler T, Steeg M, Droppa M, Jorbenadze R, Haap M, Gawaz M, Fateh-Moghadam S, Clinical outcome and paravalvular leakage of the new balloon-expandable Edwards Sapien 3 valve in comparison to its predecessor model (Edwards Sapien XT) in patients undergoing transfemoral aortic valve replacement. Catheter Cardiovasc Interv 2016 88 466 475. doi: 10.1002/ccd.26562.
28. Theron A, Pinto J, Grisoli D, Griffiths K, Salaun E, Jaussaud N, Ravis E, Lambert M, Messous L, Amanatiou C, Cuisset T, Gariboldi V, Giorgi R, Habib G, Collart F, Patient-prosthesis mismatch in new generation trans-catheter heart valves: A propensity score analysis. Eur Heart J Cardiovasc Imaging 2017. doi: 10.1093/ehjci/jex019.
29. Johnston DR, Soltesz EG, Vakil N, Rajeswaran J, Roselli EE, Sabik JF 3rd, Smedira NG, Svensson LG, Lytle BW, Blackstone EH, Long-Term durability of bioprosthetic aortic valves: implications from 12,569 implants. Ann Thorac Surg 2015 99 1239 1247. doi: 10.1016/j.athoracsur.2014.10.070.
30. Pibarot P, Barbanti M, Rudolph T, Spence M, Simonato M, Moat N, Mennuni M, Iadanza A, Amrane H, Kim W-K, Brecker S, Linke A, Finkelstein A, Spargias K, Hernandez J-M, Latib A, Dvir D, Prosthesis-patient mismatch of surgical valves significantly impacts survival following aortic valve-in-valve implantation. Abstract presented at EuroPCR 2017. May 2017
31. Matsumoto Y, Fujita T, Hata H, Shimahara Y, Sato S, Kobayashi J, Hemodynamic performance and durability of mosaic bioprostheses for aortic valve replacement, up to 13 years. Circ J 2015 79 1044 1051. doi: 10.1253/circj.CJ-14-0990.
32. Yankah CA, Pasic M, Musci M, Stein J, Detschades C, Siniawski H, Hetzer R, Aortic valve replacement with the Mitroflow pericardial bioprosthesis: durability results up to 21 years. J Thorac Cardiovasc Surg 2008 136 688 696. doi: 10.1016/j.jtcvs.2008.05.022.